Changwu Xu
- Molecular Biology
- Clinical Biochemistry top 5%
- Cancer Research
- Cardiology and Cardiovascular Medicine
- Immunology
- Co-authors
- Xiaorong HuHong JiangZhibing LuXiaoya ZhouBo CuiJing ZhangJian YangJing Chen
- Topics
- Advanced Glycation End Products research (7 papers)Atrial Fibrillation Management and Outcomes (4 papers)Cardiac Ischemia and Reperfusion (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of the American College of CardiologyPLoS ONE
In The Last Decade
Changwu Xu
33 papers receiving 749 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 344
- Clinical Biochemistry 152
- Cancer Research 122
- Cardiology and Cardiovascular Medicine 118
- Immunology 105
Countries citing papers authored by Changwu Xu
This map shows the geographic impact of Changwu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwu Xu more than expected).
Fields of papers citing papers by Changwu Xu
This network shows the impact of papers produced by Changwu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwu Xu. The network helps show where Changwu Xu may publish in the future.
Co-authorship network of co-authors of Changwu Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Changwu Xu. A scholar is included among the top collaborators of Changwu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changwu Xu. Changwu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 6 | |
| 4 | 17 | |
| 5 | 21 | |
| 6 | 12 | |
| 7 | 14 | |
| 8 | 4 | |
| 9 | 20 | |
| 10 | 37 | |
| 11 | 22 | |
| 12 | 49 | |
| 13 | 51 | |
| 14 | 16 | |
| 15 | 47 | |
| 16 | 13 | |
| 17 | 14 | |
| 18 | 41 | |
| 19 | 59 | |
| 20 | 8 |
About Changwu Xu
Changwu Xu is a scholar working on Clinical Biochemistry, Geriatrics and Gerontology and Biochemistry, having authored 33 papers that have together received 758 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (7 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). The work is most often cited by research in Clinical Biochemistry (152 citations), Geriatrics and Gerontology (53 citations) and Cancer Research (122 citations). Changwu Xu has collaborated with scholars based in China, Japan and Hong Kong. Frequent co-authors include Xiaorong Hu, Hong Jiang, Zhibing Lu, Xiaoya Zhou, Bo Cui, Jing Zhang, Jian Yang, Jing Chen, Qi Hu and Hong Jiang. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.